Geigy Report issue

Contributed to NME For profit Phase 2
Founded: Basel Switzerland (1901)
Status: Acquired by Ciba-Geigy (1971) → now Novartis (1996)

Organization Overview

First Clinical Trial
2000
NCT00000390
First Marketed Drug
1961
opipramol (Insidon)
First NDA Approval
1961
opipramol (Insidon)
Last Known Activity
2000

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

GEIGY Pharmaceuticals

Active Ingredients

Marketed Drugs (6)

bisacodyl (Halflytely) (NDA)

carbamazepine (tegretol) (1968 NDA)

chlorthalidone (Hygroton) (NDA)

desipramine (pertofrane) (1968 NDA)

opipramol (Insidon) (1961 NDA)

oxcarbazepine (trileptal) (1992)

Drugs in Phase 2 Trials (1)

imipramine (tofranil) (1 trial)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1